Heart implant offers Blood-Thinner alternative for stroke prevention
NCT ID NCT05565599
Summary
This early study is testing a small heart implant called the Laminar Left Atrial Appendage Closure System. It's designed for people with atrial fibrillation who cannot take long-term blood thinners but still need stroke prevention. The device is placed in the heart to seal off an area where blood clots often form. Researchers will follow 45 participants for 5 years to check safety and how well it works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-VALVULAR ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia U. Medical Center / NY Presbyterian Hospital
New York, New York, 10032, United States
-
Los Robles Hospital & Medical Center
Thousand Oaks, California, 91360, United States
-
Scripps Health
La Jolla, California, 92037, United States
-
St. Bernards Medical Center
Jonesboro, Arkansas, 72401, United States
-
The Mount Sinai Hospital
New York, New York, 10029, United States
-
Tucson Medical Center
Tucson, Arizona, 85712, United States
-
UC Davis Medical Center
Sacramento, California, 95817, United States
Conditions
Explore the condition pages connected to this study.